Naomi Klarenbeek (1981) studied medicine at the Erasmus University in Rotterdam. After that, she did a PhD in rheumatoid arthritis at the Rheumatology department of the Leiden University Medical Center (LUMC). She was subsequently trained as an internist at the LUMC. She joined CHDR in 2017 during her clinical pharmacology training. Currently, Naomi holds a position as Research Director Internal Medicine at CHDR. Her research is primarily focused on early drug development in systemic auto-immune diseases and metabolic/endocrine disorders.